Discontinued — last reported Q4 '25
Other
Defined Benefit Plan Recognized Net Gain Loss Due To Curtailments
Over 2 years (FY 2022 to FY 2025), Defined Benefit Plan Recognized Net Gain Loss Due To Curtailments shows an upward trend with a -100.0% CAGR.
Analysis
StatementCash Flow Statement
SectionOther
CategoryRisk
SignalContext dependent
VolatilityVolatile
First reportedQ1 2014
Last reportedQ4 2025Feb 17, 2026
How to read this metric
Large fluctuations indicate volatility in pension obligations or significant changes to employee benefit structures.
Detailed definition
This represents the non-cash impact of gains or losses recognized from changes in defined benefit pension plan obligatio...
Peer comparison
Common for mature industrial companies with legacy pension obligations.
Metric ID:
other_defined_benefit_plan_recognized_net_gain_loss_due__7cbb9aHistorical Data
15 periods
| Q2 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$100.00K | -$600.00K | -$600.00K | -$49.60M | -$1.40M | $0.00 | -$100.00K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| QoQ Change | — | -500.0% | +0.0% | <-999% | +97.2% | +100.0% | — | +100.0% | — | — | — | — | — | — | — |
| YoY Change | — | — | -500.0% | — | — | +100.0% | +92.9% | — | — | — | +100.0% | — | — | — | — |
Range-$49.60M – $0.00
CAGR-100.0%
Avg YoY Growth-51.8%
Median YoY Growth+96.4%
Defined Benefit Plan Recognized Net Gain Loss Due To Curtailments at Other Companies
Frequently Asked Questions
- What is West Pharmaceutical Services's defined benefit plan recognized net gain loss due to curtailments?
- West Pharmaceutical Services (WST) reported defined benefit plan recognized net gain loss due to curtailments of $0.00 in Q4 2025.
- What is the long-term trend for West Pharmaceutical Services's defined benefit plan recognized net gain loss due to curtailments?
- Over 2 years (2022 to 2025), West Pharmaceutical Services's defined benefit plan recognized net gain loss due to curtailments has grown at a -100.0% compound annual growth rate (CAGR), from -$52.20M to $0.00.
- What does defined benefit plan recognized net gain loss due to curtailments mean?
- Non-cash accounting gains or losses related to pension plan changes.